Fair Value Calculator Fair Value Calculator
EN DE

HRYNSHP (HRYNSHP) Fair Value & Analysis

IN · Market cap ₹623M

H HRYNSHP HRYNSHP · BSE
Price₹101.00
Fair Value₹28.79
Upside-71.5%
Quality59/100
Watch HRYNSHP for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹20.16 – ₹37.43

Fair value as of: Jul 5, 2026

From 20 valuation models · updated 3 days ago

Share price +4.1% over the past month.

Price vs Fair Value (12 months)

₹126.50 ₹85.25 Fair Value ₹28.79 Jul 2025 Jul 2026

12‑month range ₹85.25 – ₹126.50 · fair‑value band ₹20.16 – ₹37.43 · the ₹101.00 price screens above the ₹28.79 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

HRYNSHP (HRYNSHP) currently trades at ₹101.00, while our model-based Fair Value estimate is ₹28.79 — implying the stock looks roughly 71.5% overvalued today. We read business quality at 59/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, HRYNSHP generated revenue of ₹173M at a net margin of 2.3%. Revenue grew 18.4% year over year. It earns a return on equity of 0.3%. Net debt stands at ₹35.8M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹20.16 (bear case) to ₹37.43 (bull case); at ₹101.00, the current price sits above that range. The share trades about 25% below its 52-week high and 23% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹173M
Revenue growth (YoY) +18.4%
Net margin 2.3%
Return on equity 0.3%
Free cash flow ₹31.8M FY2026
P/E ratio 157.8
More key figures
Operating margin 19.4%
EPS (TTM) ₹0.6400
EPS growth (YoY) +1,503%
Net debt ₹35.8M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

HRYNSHP reported revenue of ₹35.0M in FY2026 versus ₹1.7B in FY2022, a compound −62.1%/yr. Reported net income was ₹3.9M in FY2026, compounding −32.0%/yr from FY2022.

Revenue −62.1%/yr
FY22 ₹1.7B
FY23 ₹541M
FY24 ₹1.5B
FY25 ₹2.2M
FY26 ₹35.0M
Net income −32.0%/yr
FY22 ₹18.4M
FY23 ₹41.1M
FY24 ₹32.3M
FY25 ₹16.0M
FY26 ₹3.9M

Is HRYNSHP fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "HRYNSHP Fair Value". https://www.fairvalue-calculator.com/stock/HRYNSHP

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is HRYNSHP (HRYNSHP) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹28.79 versus a price of ₹101.00 — about −71% (overvalued). Model-based estimate, not financial advice.
What is the fair value of HRYNSHP?
Our model-based fair value for HRYNSHP is ₹28.79 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹101.00.
What is the quality score of HRYNSHP?
HRYNSHP has a Quality Score of 59/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of HRYNSHP (HRYNSHP)?
HRYNSHP reported trailing-twelve-month revenue of about ₹173M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of HRYNSHP?
The net profit margin of HRYNSHP is about 2.3%, meaning it keeps roughly 2.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.